5 days ago · BIIB stock construct a change of 0.08 in a total of its share price and finished its trading at 316.38. Biogen Inc. institutional ownership is held at 90.40% while insider ownership was 0.10%. As of now, BIIB has a P/S, P/E and P/B values of 3.94, 10.05 and 4.22 respectively. Its P/Cash is valued at 12.64.

BIIB, Biogen Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. How Merck Stock Can Hit All-Time Highs Now · By Bret Kenwell. Oct 29, 2019 1: 05 PM EDT. We Got Too Negative: Cramer's 'Mad Money' Recap (Monday 4/9. Found this lol I know $BIIB is looking real dumb now. Last few clinical trials have met endpoints above expectations. 1. View live BIOGEN INC chart to track its stock's price action. Find market BIIB: Price and Indicator Divergence Before Pop -- caution now. BradfordFournier Feb   Presenting BIIB historical stock prices and CAGR performance. purchase of BIIB, and working forward through the historical stock price information to today.

March 2020 Options Now Available For Biogen (BIIB) | Nasdaq

View BIIB's stock price, price target, earnings, financials, forecast, insider Since then, BIIB shares have increased by 2.1% and is now trading at $300.51. Biogen Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. View Biogen Inc. BIIB investment & stock information. Get the latest Biogen Inc. BIIB detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 23 Mar 2020 Biogen Inc. (BIIB) stock changed position at -3.21% to closing price of capacity stands with 1.90M shares and relative volume is now at 1.42. BIIB, Biogen Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. How Merck Stock Can Hit All-Time Highs Now · By Bret Kenwell. Oct 29, 2019 1: 05 PM EDT. We Got Too Negative: Cramer's 'Mad Money' Recap (Monday 4/9. Found this lol I know $BIIB is looking real dumb now. Last few clinical trials have met endpoints above expectations. 1.

Biogen - 29 Year Stock Split History | BIIB | MacroTrends

BIIB.US | Biogen Inc. Stock Price & News - WSJ View the latest Biogen Inc. (BIIB.US) stock price, news, historical charts, analyst ratings and financial information from WSJ. Biogen Inc. [BIIB] is 6.54% higher this YTD. Is it still ...

Presenting BIIB historical stock prices and CAGR performance. purchase of BIIB, and working forward through the historical stock price information to today.

BIIB Stock Summary. BIIB has a higher market value than 96.91% of US stocks; more precisely, its current market capitalization is $48,074,739,198. Biogen Inc's stock had its IPO on September 17, 1991, making it an older stock than 82.6% of US equities in our set. Read this if you are finding opportunities:: Biogen Inc ... 3 days ago · BIIB stock construct a change of 3.82 in a total of its share price and finished its trading at 304.47. Biogen Inc. institutional ownership is held at 90.40% while insider ownership was 0.10%. As of now, BIIB has a P/S, P/E and P/B values of 3.79, 9.67 and 4.06 respectively. Its P/Cash is valued at 12.17. BMY Stock Pops On Multiple Sclerosis Treatment Approval ... Shares of BMY stock popped Thursday after the pharmaceutical company grabbed U.S. approval for a key multiple sclerosis treatment. X. The Food and Drug Administration approved ozanimod, now known Biogen Stock Quote. BIIB - Stock Price, News, Charts ...

Stock split history for Biogen since 1991. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.

Biogen - 29 Year Stock Split History | BIIB | MacroTrends Stock split history for Biogen since 1991. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values. BIIB.US | Biogen Inc. Stock Price & News - WSJ View the latest Biogen Inc. (BIIB.US) stock price, news, historical charts, analyst ratings and financial information from WSJ. Biogen Inc. [BIIB] is 6.54% higher this YTD. Is it still ... 6 days ago · The new note on the price target was released on January 27, 2020, representing the official price target for Biogen Inc. stock. Previously, the target price had yet another raise from $260 to $300, while Credit Suisse kept a Neutral rating on BIIB stock. BIIB | Biogen Inc. Historical Quotes | MarketWatch

Alteration today:: Biogen Inc., (NASDAQ: BIIB) – News Smooth 8 hours ago · The Stock Price moved with change of 14.59% to its 50 Day low spot and changed -19.86% contrasting with its 50 Day high point.As of now, BIIB. has a P/S, P/E and P/B values of 3.69, 9.55 and 4.00 respectively. Its P/Cash is valued at 11.84.